198 related articles for article (PubMed ID: 30718065)
1. A coupled framework of in situ and in silico analysis reveals the role of lateral force transmission in force production in volumetric muscle loss injuries.
Westman AM; Dyer SE; Remer JD; Hu X; Christ GJ; Blemker SS
J Biomech; 2019 Mar; 85():118-125. PubMed ID: 30718065
[TBL] [Abstract][Full Text] [Related]
2. Photoreactive Hydrogel Stiffness Influences Volumetric Muscle Loss Repair.
Basurto IM; Passipieri JA; Gardner GM; Smith KK; Amacher AR; Hansrisuk AI; Christ GJ; Caliari SR
Tissue Eng Part A; 2022 Apr; 28(7-8):312-329. PubMed ID: 34409861
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Evaluation of Functional Outcomes Following Rat Volumetric Muscle Loss Injury and Repair.
Mintz EL; Passipieri JA; Franklin IR; Toscano VM; Afferton EC; Sharma PR; Christ GJ
Tissue Eng Part A; 2020 Feb; 26(3-4):140-156. PubMed ID: 31578935
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix scaffolds for treatment of large volume muscle injuries: A review.
Sarrafian TL; Bodine SC; Murphy B; Grayson JK; Stover SM
Vet Surg; 2018 May; 47(4):524-535. PubMed ID: 29603757
[TBL] [Abstract][Full Text] [Related]
5. Recovery from volumetric muscle loss injury: A comparison between young and aged rats.
Kim JT; Kasukonis BM; Brown LA; Washington TA; Wolchok JC
Exp Gerontol; 2016 Oct; 83():37-46. PubMed ID: 27435497
[TBL] [Abstract][Full Text] [Related]
6. Keratin Hydrogel Enhances In Vivo Skeletal Muscle Function in a Rat Model of Volumetric Muscle Loss.
Passipieri JA; Baker HB; Siriwardane M; Ellenburg MD; Vadhavkar M; Saul JM; Tomblyn S; Burnett L; Christ GJ
Tissue Eng Part A; 2017 Jun; 23(11-12):556-571. PubMed ID: 28169594
[TBL] [Abstract][Full Text] [Related]
7. Regenerative and Rehabilitative Medicine: A Necessary Synergy for Functional Recovery from Volumetric Muscle Loss Injury.
Greising SM; Dearth CL; Corona BT
Cells Tissues Organs; 2016; 202(3-4):237-249. PubMed ID: 27825146
[TBL] [Abstract][Full Text] [Related]
8.
Passipieri JA; Hu X; Mintz E; Dienes J; Baker HB; Wallace CH; Blemker SS; Christ GJ
Tissue Eng Part A; 2019 Sep; 25(17-18):1272-1288. PubMed ID: 30882277
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of Volumetric Muscle Loss Injury.
Corona BT; Wenke JC; Ward CL
Cells Tissues Organs; 2016; 202(3-4):180-188. PubMed ID: 27825160
[TBL] [Abstract][Full Text] [Related]
10. A 30% Volumetric Muscle Loss Does Not Result in Sustained Functional Deficits after a 90-Day Recovery in Rats.
Vega-Soto EE; Rodriguez BL; Armstrong RE; Larkin LM
Regen Eng Transl Med; 2020 Mar; 6(1):62-68. PubMed ID: 32258383
[TBL] [Abstract][Full Text] [Related]
11. Agent-based model provides insight into the mechanisms behind failed regeneration following volumetric muscle loss injury.
Westman AM; Peirce SM; Christ GJ; Blemker SS
PLoS Comput Biol; 2021 May; 17(5):e1008937. PubMed ID: 33970905
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Approaches for Volumetric Muscle Loss Injury: A Systematic Review and Meta-Analysis.
Greising SM; Corona BT; McGann C; Frankum JK; Warren GL
Tissue Eng Part B Rev; 2019 Dec; 25(6):510-525. PubMed ID: 31578930
[TBL] [Abstract][Full Text] [Related]
13. Muscle-derived decellularised extracellular matrix improves functional recovery in a rat latissimus dorsi muscle defect model.
Chen XK; Walters TJ
J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):1750-8. PubMed ID: 24007646
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Engineered Skeletal Muscle on Volumetric Muscle Loss in The Tibialis Anterior Of Rat After Three Months
Nutter GP; VanDusen KW; Florida SE; Syverud BC; Larkin LM
Regen Eng Transl Med; 2020 Dec; 6(4):365-372. PubMed ID: 33778156
[TBL] [Abstract][Full Text] [Related]
15. The Potential of Combination Therapeutics for More Complete Repair of Volumetric Muscle Loss Injuries: The Role of Exogenous Growth Factors and/or Progenitor Cells in Implantable Skeletal Muscle Tissue Engineering Technologies.
Passipieri JA; Christ GJ
Cells Tissues Organs; 2016; 202(3-4):202-213. PubMed ID: 27825153
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical Agents for Contractile-Metabolic Dysfunction After Volumetric Muscle Loss.
McFaline-Figueroa J; Schifino AG; Nichenko AS; Lord MN; Hunda ET; Winders EA; Noble EE; Greising SM; Call JA
Tissue Eng Part A; 2022 Sep; 28(17-18):795-806. PubMed ID: 35620911
[TBL] [Abstract][Full Text] [Related]
17. The effect of autologous repair and voluntary wheel running on force recovery in a rat model of volumetric muscle loss.
Washington TA; Perry RA; Kim JT; Haynie WS; Greene NP; Wolchok JC
Exp Physiol; 2021 Apr; 106(4):994-1004. PubMed ID: 33600045
[TBL] [Abstract][Full Text] [Related]
18. Laminin-111-Enriched Fibrin Hydrogels Enhance Functional Muscle Regeneration Following Trauma.
Ziemkiewicz N; Hilliard GM; Dunn AJ; Madsen J; Haas G; Au J; Genovese PC; Chauvin HM; West C; Paoli A; Garg K
Tissue Eng Part A; 2022 Apr; 28(7-8):297-311. PubMed ID: 34409846
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the potential use of functional fibrosis to facilitate improved outcomes following volumetric muscle loss injury.
Dolan CP; Motherwell JM; Franco SR; Janakiram NB; Valerio MS; Goldman SM; Dearth CL
Acta Biomater; 2022 Mar; 140():379-388. PubMed ID: 34843950
[TBL] [Abstract][Full Text] [Related]
20. Applications of In Vivo Functional Testing of the Rat Tibialis Anterior for Evaluating Tissue Engineered Skeletal Muscle Repair.
Mintz EL; Passipieri JA; Lovell DY; Christ GJ
J Vis Exp; 2016 Oct; (116):. PubMed ID: 27768064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
